Show of strength for CR Pharma as $2bn IPO launches
China Resources Pharmaceutical Group’s HK$15.7bn ($2.0bn) Hong Kong IPO got off to a flying start this week, with books covered and support from high profile cornerstone investors giving it momentum.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: